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Hospital for Sick Children, Toronto, Ontario, Canada. 2 The Biotechnology Centre of Oslo, University of Oslo, Oslo, Norway. 3 Biomedical complexes are not directly (or automatically) comparable across different sources. Taken together, our analyses highlight the profound impact of nonuniform data curation practices on shaping the data collectively curated by PPI databases. The need to harmonize them is clearer than ever because even the major databases contribute only a fraction of unique interactions to the pool (Fig. 1b) .
Why do these problems exist, despite the curation policies advocated by the IMEx consortium (http://www.imexconsortium. org/curation-rules)? One reason is that much of the data currently archived in the databases predate the consortium existence or are contributed by non-IMEx databases. Many of the discrepancies we identified should in the future be eliminated if the IMEx guidelines are widely followed. For example, IMEx rules prohibit curation where the organism taxon cannot be identified, recommend the group representation for complexes, require that all interactions in a paper be curated if possible and stipulate that authorprovided confidence scores and warnings be incorporated where available. PPI records would also benefit from the use of controlled vocabulary terms that flag splice-isoform and organism assignments that are arbitrary or uncertain.
Our results therefore suggest that all PPI databases should adopt standard curation policies. A very important element in implementing such policies would be an effective auditing mechanism. Such a mechanism would require different databases to process a large enough number of publications curated by at least two databases. Annotated information from these publications could then be analyzed for compliance with the common guidelines, using similar methods as those we employed. Unfortunately, this could not be done to evaluate IMEx-compliant curations because the current policy of the IMEx consortium is to distribute the curation load among member databases, thereby essentially eliminating the curation of shared publications. We suggest that this policy should be revised.
Tools, such as iRefWeb, have an important role to play as they allow both curators and data consumers to examine, compare and contrast various supporting data for their interactions of interest and trace it to the original database records and publications. Further analysis-most likely involving manual recuration-is clearly necessary to resolve discrepancies and, possibly, to identify incorrect annotations, but the availability of automatic tools is an important first step PathSeq: software to identify or discover microbes by deep sequencing of human tissue To the Editor: Many human diseases are believed to be caused by undiscovered pathogens 1, 2 . The advent of next-generation sequencing technology presents an unprecedented opportunity to identify pathogens in hitherto idiopathic diseases. Here we present PathSeq, a highly scalable software tool that performs computational subtraction on high-throughput sequencing data to identify nonhuman nucleic acids that may indicate candidate microbes. PathSeq exhibits high sensitivity and specificity in its ability to discriminate human from nonhuman sequences using both simulated and experimental transcriptome and whole-genome sequencing data. PathSeq is implemented in a cloud computing environment making it readily accessible by the scientific community.
Previously, our group and others have developed a computational approach to pathogen discovery, sequence-based computational subtraction [3] [4] [5] [6] . This method is based on the premise that infected tissues contain both human and microbial nucleic acids and that novel pathogen-derived sequences can be detected after subtracting human sequences. This unbiased approach to pathogen discovery is an advance over targeted PCR or pan-microbial array methods because it requires no sequence information ab initio about the organism being sought (for a recent, in-depth review of pathogen discovery methods, see ref.
2). Even so, performing computational subtraction at any meaningful scale was initially cost prohibitive as this method requires a large number of input sequences, given that any pathogen present is likely to have low nucleic acid representation relative to that of the human host.
With the recent development of nextgeneration sequencing methods 7, 8 , computational subtraction-based pathogen discovery has now become a viable option. For example, massively parallel pyrosequencing combined with computational subtraction has resulted in the discovery of novel viruses in human disease-Merkel cell polyomavirus in Merkel cell carcinoma 9 and a novel Old World arenavirus in a cluster of patients with fatal transplant-associated disease 10 . Indeed, genome coverage (Supplementary Methods and Supplementary Tables 1 and 2). To increase the likelihood of discovering a novel organism, all unmapped reads are de novo assembled using the short-read assembler Velvet 12 . The formation of large contigs comprising several unmapped reads that do not possess significant alignment similarity to any sequence in the reference databases may be suggestive of a previously undetected organism.
To demonstrate the utility of PathSeq, we have used simulated data to assess the ability of the method to (i) efficiently subtract human-derived sequences and appropriate reference genome databases.
The analytic phase of PathSeq comprises several steps that are performed in parallel (Fig. 1b) . To identify previously sequenced microbes, all unmapped reads are aligned to reference viral, bacterial and fungal sequence databases by BLASTN and BLASTX. To assess the bacterial composition of a sample containing a rich microbiome, PathSeq performs a metagenomic analysis by aligning all unmapped reads to the complete collection of currently sequenced whole bacterial genomes and quantifying bacterial representation by a measure of both the total number of aligned reads and the bacterial the past few years have seen steep drops in price and increases in throughput for nextgeneration sequencing technologies, and these trends are expected to accelerate in the near future 7, 8 . Even so, this advancement in technology brings with it new computational challenges. Analyzing sequence data using the computational subtraction method is computationally expensive relative to most other next-generation sequencing analyses because it requires subtractive alignments to several large reference databases using local alignment algorithms such as BLAST.
PathSeq is a comprehensive computational tool for the analysis of the non-host portion of resequencing data that is capable of detecting the presence of both known and novel pathogens as well as any resident microorganisms. The software runs efficiently on sequence data sets of any size in a scalable and completely reproducible fashion because it is developed on a parallel computing architecture and is implemented in a cloud-computing environment. The PathSeq software package is available for public use in the form of a machine image for cloud computing, which can be launched and monitored using no more than a basic laptop computer. We believe that PathSeq opens the way for a new large-scale effort in pathogen discovery by any researcher with access to deep sequencing data from human tissue.
PathSeq's approach begins with a subtractive phase in which input reads are subtracted by alignment to human reference sequences (Fig. 1a) . This is followed by an analytic phase in which the remaining reads are aligned to microbial reference sequences and assembled de novo. The input reads are first filtered to remove low-quality, duplicate and repetitive sequences. The initial subtractive alignments are performed using the rapid short-read aligner MAQ 11 against five reference human sequence databases, including both genomic DNA and transcriptome references (Supplementary Methods). At the end of each subtractive alignment step, mapped reads are discarded and unmapped reads are subjected to further subtractive analyses. In the final steps, the residual reads are aligned to two additional human reference databases first using the Mega BLAST algorithm and then BLASTN. This identifies alignable reads with additional mismatches and/or short gaps that are not aligned by MAQ. The set of reads that remain unmapped after the subtractive phase are candidate nonhuman, pathogenderived reads. A similar schema may be used for other host organisms by substituting the (ii) minimize the subtraction of microbederived sequences (Fig. 2a) . We created a simulated sequence data set by combining sequences generated from a reference human transcriptome database and several virus genomes (Supplementary Fig. 1 ). Twenty million 100-mers were randomly generated from the reference transcriptome. The simulated virus reads were generated from 12 viral genomes; each viral genome was substitutionally mutated randomly at 12 distinct rates (0%, 1%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80% and 90%) to simulate unknown viruses at different evolutionary distances from known viruses, producing 1,000 reads per mutated genome for a total of 144,000 (12 × 12 × 1,000) virus reads.
After the subtractive steps of the PathSeq pipeline, all 20 million human transcriptome-derived reads were correctly identified as human, and only 1,122 (0.78%) reads derived from virus genomes were subtracted (Fig. 2a) . Of these 1,122 reads, 1,120 were identified as repetitive sequences and the remaining 2 reads were subtracted because of alignment similarity to the human genome (Supplementary Table 3) .
To model the performance of PathSeq on low-quality sequence data, we introduced 'sequencing errors' into this same read-set based on the distribution of actual Illumina (San Diego) HiSeq sequencing errors and found that this did not significantly affect the performance of PathSeq ( Supplementary  Fig. 2, Supplementary Table 4 and Supplementary Methods). With the exception of human rhinovirus A, which contained many repetitive sequences, >97% of all nonmutated, virus-derived reads were correctly identified by alignment to the viral nucleotide database, and >50% were still correctly identified at a substitutional mutation rate of >20% ( Supplementary  Fig. 3a) . Sequence alignment following de novo assembly allowed the identification of sequences with an even higher mutation rate (Supplementary Fig. 3b) . We note that the presence of large, unidentifiable contigs in experimental sequence data could suggest the presence of a novel microbe lacking sequence homology to known microbes and propose that such a result should justify follow-up by PCR, 3′-or 5′-random amplification of cDNA ends (RACE) and Sanger sequencing.
This notion of identifying the presence of microbes by contig formation prompted us to ask how many reads are required to form sufficiently large contigs. The probability of forming contigs from reads originating Figure 2 PathSeq performance on simulated and experimental sequence data. (a) Reads were generated by sampling random 100-mer sequences from a human transcriptome database to produce 20 million reads, and from a set of 12 virus genomes each substitutionally mutated at 12 distinct rates, generating 144,000 reads ( Supplementary Fig. 1 non-HPV18 reads. We then collected all of the HPV18 reads and searched for those whose pair-mate aligned to the human reference genome. This allowed us to identify the integration site of the viral genome in a region of chromosome 8q24 between positions 128,300,300 and 128,310,400, just upstream of the MYC oncogene. One longstanding goal of computational subtraction is the identification and characterization of every read in a data set. Although the sensitivity and specificity data for PathSeq are impressive, it still leaves 0.00076% of the ovarian whole-genome sequence reads and 0.013% of the HeLa RNA-Seq reads unaccounted for. This shortfall might be explained by error-ridden sequences passing the quality filter, reads that map to the splice junction of rare splice variants in RNA-Seq data, or reads that map to regions of the human genome that have not yet been characterized. Several groups have recently reported novel human genome sequences by de novo assembly of next-generation whole-genome sequence data 13, 14 or by using a fosmid end-sequence pair-mapping approach 15 . Ideally, these new sequences could form a subtractive database for PathSeq and help reduce the total number of reads unaccounted for. However, by performing a simple Mega BLAST alignment of these sequences to microbial databases, we found that many sequences from all three above-mentioned studies [13] [14] [15] have perfect matches to known bacteria, fungi and viruses ( Supplementary  Data Sets 1-3) , raising the question of whether they may contain novel microbes as well. Therefore, an essential next step in the improvement of computational subtractionbased methods is the creation of a reliable database of human genome scaffolds that extend the current human reference genome.
Taken together, our results demonstrate the ability of PathSeq to identify both known and novel microorganisms in highthroughput human resequencing data. Just as current metagenomic surveys of the world's oceans and soils are yielding remarkable new organisms, so too do we expect to uncover new viruses, bacteria and fungi in human tissue with important medical implications. We are making PathSeq available for public use (http://www.broadinstitute.org/software/ pathseq/) and it is our hope that investigators will use this tool to join our efforts in pathogen discovery. from a single genome is a function of two variables: first, the size in base pairs of the genome in question; and second, the number of reads derived from the genome. We simulated the ability of Velvet, the short read assembler used in PathSeq, to form contigs that are at least 1.75 times the size of the input reads from a genome by randomly generating reads from genomes of varying length (Supplementary Fig. 4) . We found that there is a >75% chance of forming contigs from genomes as large as 20 kb when only 20 reads are derived from the genome (using 100-bp reads). This suggests that relying on contig assembly to indicate the presence of a novel genome may be a practical approach.
We then tested the performance of PathSeq on a set of sequences representing many-fold coverage of the whole genome of a serous ovarian carcinoma tumor that was sequenced as part of The Cancer Genome Atlas (Supplementary Methods).
Starting with slightly more than 1.7 billion reads of 101 bp each, we first removed mapped reads following initial alignment to the reference human genome and then performed stringent quality filtering to yield 26.3 million reads. We ran these sequences on PathSeq and were left with a final set of 13,019 reads after subtraction, <0.001% of the original reads (Fig. 2b) . The analytic phase of PathSeq did not yield any evidence that the remaining reads were derived from a pathogen; rather, they likely represented yet-uncharacterized regions of the human genome or sequencing artifacts. This substantial subtraction efficiency (99.9992%) demonstrates that the performance of PathSeq on simulated data can indeed be extended to real, human whole-genome sequencing.
We next generated sequence data from HeLa cervical cancer cell lines with the expectation of finding human papillomavirus (HPV) type 18. We sequenced a cDNA library generated from total RNA isolated from HeLa cells on a single lane of Illumina sequencing, generating 10.3 million quality-and purityfiltered 76-bp reads. We applied these sequence data to PathSeq (Fig. 2c) . Humanderived reads were efficiently subtracted during the subtractive phase such that 0.30% of input reads remained unmapped. Out of these 30,790 reads, 25,879 were identified as HPV 18, leaving 4,911 non-human,
